Tirofiban Hydrochloride Monohydrate (CAS 150915-40-5) Suppliers and Product Information

Tirofiban hydrochloride monohydrate is a potent non-peptide glycoprotein IIb/IIIa inhibitor used as an antithrombotic agent. It is primarily used in the treatment of acute coronary syndromes, including unstable angina and non-Q-wave myocardial infarction. The drug works by preventing platelet aggregation and thrombus formation.

Frequently Asked Questions

Q: What is the main use of Tirofiban hydrochloride monohydrate?

A: Tirofiban hydrochloride monohydrate is primarily used in combination with heparin for treating acute coronary syndromes, including unstable angina or non-Q wave myocardial infarction, and in patients undergoing percutaneous transluminal coronary angioplasty (PTCA) or atherectomy artery surgery.

Q: How does Tirofiban work?

A: Tirofiban is a reversible, non-peptide platelet surface glycoprotein (GP) IIb/IIIa receptor antagonist. It competitively inhibits the combination of fibrinogen and platelet GP IIb/IIIa receptor, thereby preventing platelet aggregation and thrombus formation.

Q: What are the common side effects of Tirofiban?

A: The most common adverse reactions to Tirofiban are fever and bleeding complications. Other visible adverse reactions include nausea, headache, rash or urticaria. A systemic reaction that may occur is a reduction in platelet count.